Contract Research Organization Services Market Development and Demand Forecast to 2030

1. Contract Research Organization Services Market Will Reach USD 142.56 Billion by 2030 1 © Prescient & Strategic Intelligence Private Limited. All rights reserved

2. In 2022, the global contract research organization services market had a total size of USD 64.60 billion, and it is projected to hit USD 142.56 billion by 2030, progressing at a rate of 10.4% from 2022 to 2030, according to a research report by a market research company P&S Intelligence. This development can be credited to the high price of in-house medication growth and technological improvements in clinical trials, and such services help in pharmacovigilance, trial planning, site access, data analysis, and hospital staffing. As people age, more illnesses arise as the body declines and numerous health problems initiate, and individuals typically tend to become more disposed to illnesses as the immune system inclines to become slower. As per the government reports, in the U.S., around one in five Americans will be old 65 years or more by 2040. At such an age, as the odds of getting sick surge, they need drugs to keep their well-being maintained. For this, clinical trials are required, which will, ultimately, drive the requirement for CRO services. Also, the requirement for these services is growing because these are lucrative to outsource. Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/cro-services- market/report-sample Oncology is an extensive application area in the market. This is mainly because of the growing occurrence of cancer and the growth of numerous medicinal devices and many therapies for the cure of cancer. The growth is only thinkable with the increase in the count of cancer clinical trials. For example, the count of such trials stood at 1,489 in 2021. Furthermore, the standard shift toward precision drugs among people and medication makers is rising due to progressive genetic sequencing technologies and new molecular targets. Also, interventional investigations became more expensive and difficult, and take more time than normal due to strict governing protocols and drawbacks. Because of such factors, the industry is emerging in this area. North America is dominating the contract research organization services market, and the continent is also projected to be on the leading spot throughout the forecast period, with a worth of USD 74,134 million. This can be credited to the high healthcare investments, enormous expenditure in interventional studies, the growing count of chronic illnesses armed with a 2 © Prescient & Strategic Intelligence Private Limited. All rights reserved

3. huge count of patients suffering from such diseases, and governments are progressively investing in this field in the continent. Moreover, the continent has high personal revenue, because of which the requirement for technologically progressive items has augmented and individuals are able to invest widely in healthcare services. Also, there is robust healthcare awareness among people and high expenditure for the growth of new drugs. Hence, the high price of in-house medication growth and technological improvements in clinical trials, and such services help in pharmacovigilance, trial planning, site access, data analysis, and hospital staffing. Browse full report at: https://www.psmarketresearch.com/market- analysis/cro-services-market Contract Research Organization Services Market Size Breakdown by Segment By Type Clinical Research Services oPhase I clinical research services oPhase II clinical research services oPhase III clinical research services oPhase IV clinical research services Early Phase Development Services oChemistry, manufacturing and control services oPreclinical services oDiscovery studies Laboratory Services oAnalytical testing services oBioanalytical testing services Consulting Services Data Management Services • • • • • By Application Oncology Infectious Diseases Immunological Disorders Metabolic Disorders Respiratory Disorders Cardiovascular Diseases Neurological Disorders • • • • • • • 3 © Prescient & Strategic Intelligence Private Limited. All rights reserved

4. By End Users Pharmaceutical and biopharmaceutical companies - largest Medical device companies Academic institutes • • • Regional Analysis North America oU.S. oCanada Europe oGermany oU.K. oFrance oItaly oSpain Asia-Pacific oJapan oChina oIndia oSouth Korea oAustralia Latin America oBrazil oMexico Middle East and Africa oSaudi Arabia oSouth Africa oU.A.E. • • • • • 4 © Prescient & Strategic Intelligence Private Limited. All rights reserved

5. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 4 ©P&SIntelligence.Allrightsreserved 5 © Prescient & Strategic Intelligence Private Limited. All rights reserved